It is common, if not, expected, that participation in PBM networks will subject pharmacies to audits. During these audits, PBMs will review a number of claims submitted by a provider during a specified period of time. Although the purported reason... Read More
Recently, Frier Levitt successfully represented a community pharmacy located in New Jersey facing an investigation stemming from a patient complaint. More specifically, a patient had submitted a complaint to the Board of Pharmacy regarding the... Read More
While the year may be coming to an end, PBMs are gearing up to perform even more audits on their pharmacy providers. PBMs perform audits to monitor provider compliance all year round, but have been observed to increase frequency at the end of the... Read More
As we approach the end of the calendar year, Pharmacy Benefit Managers (PBMs) engage in a crucial process - the review of pharmacies within their networks. This review encompasses a comprehensive assessment of various facets of pharmacy operations,... Read More
Recently, there has been an increase in the emergence of third-party companies specializing in assisting physicians and facilities obtain access to “unclaimed” rebates from manufacturers for prescription drugs. These rebates pertain to drugs... Read More
The rising cost of prescription drugs impacts all members of the pharmacy supply chain. For patients, it likely means higher copay or co-insurance responsibilities under their prescription benefit plan. Excessive patient pay amounts deter... Read More
Florida’s Prescription Drug Reform Act, Senate Bill 1550 (“Act”), which took effect on July 1, 2023, includes anti patient steering provisions that Florida-based pharmacies and pharmacists should be aware of. Patient steering is a practice... Read More
Frier Levitt is pleased to share the latest edition of our Life Sciences Newsletter. Keeping you informed on current topics impacting pharmacies, drug manufacturers, and plan sponsors. Topics include the impact of PCMA v. Mulready on independent... Read More
In a statement released on September 19, 2023, pharmaceutical company Eli Lilly has announced that it has initiated legal proceedings against certain medical spas, wellness centers, and compounding pharmacies in the U.S. The company is attempting to... Read More
On September 18, 2023, Governor DeSantis took the next steps toward increasing Pharmacy Benefit Manager (“PBM”) accountability and transparency in the State of Florida by approving rules that implement the Prescription Drug Reform Act Senate... Read More
